Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


The Hospital for Sick Children

Latest From The Hospital for Sick Children

Venture Funding Deals, March 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a monthly review of emerging In Vitro Diagnostic, Medical Device, and Pharmaceutical companies that have received venture funding. This month’s column covers deals announced January through February 2016.

BioPharmaceutical Medical Device

Life Science Start-Ups: Tech Transfer Deals, November 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Tech Transfers column provides a monthly update on technology transfer deals, reporting licensing agreements between companies and universities or other research institutions within the In Vitro Diagnostics, Medical Devices, and Pharmaceuticals sectors. This month’s column covers deals announced September through October 2013.

BioPharmaceutical Medical Device

SensorChem International Corp

SensorChem is developing an acoustic-wave-based system, which is more sensitive and faster than other technologies used to address the bottleneck created when drug researchers try to convert hits into leads.

BioPharmaceutical Strategy

HepaVec AG

With technology licensed from the Max Planck Society, HepaVec is developing liver-specific viral vector systems for human gene therapy. Also liver tissue engineering.

See All

Company Information

  • Industry
  • Academic and Research Institutions